title: Generation of effective vaccines against liver cancer by using photodynamic therapy.
abstract: Preclinical studies have shown that photodynamic therapy (PDT) enhances immune responses. To examine the role of the direct effects of PDT in liver cancer with regard to enhancement of the antitumor response, we injected PDT-generated H22 liver cancer cell lysate (as a tumor vaccine) intradermally into Kunming mice. In the control group, the cell lysate was substituted with normal saline solution. A liver tumor model was established by the injection of H22 cell suspension. We found that the PDT-generated vaccine significantly increased the percentages of CD4(+), CD8(+), and CD19(+) cells, inhibited tumor growth, and prolonged the survival time. Our findings suggest that PDT-generated vaccines can significantly enhance the antitumor immune response and may have the potential to be used as an adjuvant therapy clinically.
authors.affiliation: Laser Medicine Laboratory of Tianjin Medical University, Tianjin, PR China.
authors.forename: Hongyu
authors.initials: H
authors.lastname: Zhang
authors.forename: Wenjiang
authors.initials: W
authors.lastname: Ma
authors.forename: Yingxin
authors.initials: Y
authors.lastname: Li
mesh_terms: D000818:Animals; D019496:Cancer Vaccines / Q000302:isolation & purification* / Q000627:therapeutic use*; D045744:Cell Line, Tumor; D003131:Combined Modality Therapy; D005260:Female; D007111:Immunity, Cellular; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D028022:Low-Level Light Therapy; D016131:Lymphocyte Subsets / Q000276:immunology; D008297:Male; D051379:Mice; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000627:therapeutic use
chemical_list: D019496:Cancer Vaccines; D017319:Photosensitizing Agents
references.citation: Cancer Res. 1999 Apr 15;59(8):1941-6
references.pmid: 10213504
references.citation: Cancer Res. 2005 Feb 1;65(3):1018-26
references.pmid: 15705903
references.citation: Cancer Immunol Immunother. 2006 Aug;55(8):900-9
references.pmid: 16215717
references.citation: Cancer Res. 2002 Mar 15;62(6):1604-8
references.pmid: 11912128
references.citation: Anticancer Res. 2000 Jul-Aug;20(4):2665-76
references.pmid: 10953341
references.citation: World J Gastroenterol. 2004 Mar 1;10(5):630-3
references.pmid: 14991927
references.citation: Br J Cancer. 2003 Jun 2;88(11):1772-9
references.pmid: 12771994
references.citation: J Natl Cancer Inst. 1998 Jun 17;90(12):889-905
references.pmid: 9637138
references.citation: Cell. 2001 Aug 10;106(3):271-4
references.pmid: 11509176
references.citation: Cancer Lett. 2002 Sep 8;183(1):43-51
references.pmid: 12049813